XLY.V · Auxly Cannabis Group Inc

-

Please sign in to comment on XLY.V

1 Comment

Admin

3 years, 7 months ago

Auxly Cannabis Group Inc is currently in a long term uptrend where the price is trading 18.9% above its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.8.

Auxly Cannabis Group Inc's total revenue rose by 731.7% to $13M since the same quarter in the previous year.

Its net income has dropped by 3.2% to $-18M since the same quarter in the previous year.

Finally, its free cash flow grew by 46.6% to $-14M since the same quarter in the previous year.

Based on the above factors, Auxly Cannabis Group Inc gets an overall score of 4/5.

Industry	Drug Manufacturers-Specialty & Generic
Sector	Healthcare
ISIN	CA05335P1099
CurrencyCode	CAD
Exchange	V

Beta	2.38
Dividend Yield	0.0%
Target Price	0.58
PE Ratio	None
Market Cap	290M

ABOUT

Auxly Cannabis Group Inc

Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company engages in the cultivation of cannabis; and development and distribution of cannabis products. It offers products, such as soft chews, vape cartridges, vape pens, pre-rolled cannabis, chocolates, and cannabis oil spray and oil drops through retail stores under the Kolab Project, Foray, and Dosecan brand names. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada.

XLY.V · Auxly Cannabis Group Inc

-

Auxly Cannabis Group Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Auxly Cannabis Group Inc using a moving average strategy